Search Results

Evaluating Hepatotoxicity: A Comparative Analysis of New Generation versus Historical Antiretroviral Agents.

• Authors : Abu-Awwad, Simona-Alina^1,2 (AUTHOR) ; Abu-Awwad, Ahmed^3,4 (AUTHOR) ; Suba, Madalina-Ianca^5,6 (AUTHOR)

• Source: Infectious Disease Reports. Jun2024, Vol. 16 Issue 3, p423-434. 12p.

Record details

Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women. (PANNA)

• Authors : PENTA Foundation; Merck Sharp & Dohme LLC; Bristol-Myers Squibb

• Source: Study on Pharmacokinetics of Newly Developed ANtiretroviral Agents in HIV-infected pregNAnt Women (PANNA)Colbers AP, Hawkins DA,

Record details

Resistance Trends of Antiretroviral Agents in People with Human Immunodeficiency Virus in Korea, 2012 - 2020.

• Authors : Sang-Min Oh^1,2; Jihwan Bang²; Sang-Won Park²

• Source: Infection & Chemotherapy. Sep2023, Vol. 55 Issue 3, p328-336. 9p.

Record details

Assessment of Drug-drug Interactions Between Masculinizing Hormone Therapy and Antiretroviral Agents Concomitantly for Pre-exposure Prophylaxis Among Transgender Men

• Source: Institute of HIV Research and Innovation (IHRI)

Record details

Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With Other Antiretroviral Agents in People Living With HIV (CALIBRATE)

• Source: A Phase 2 Randomized, Open Label, Active Controlled Study Evaluating the Safety and Efficacy of Long-acting Capsid Inhibitor GS-6207 in Combination With Other

Record details

Learning from the first: a qualitative study of the psychosocial benefits and treatment burdens of long‐acting cabotegravir/rilpivirine among early adopters in three U.S. clinics.

• Authors : Christopoulos, Katerina A.¹ (AUTHOR) ; Smith, Mollie B.² (AUTHOR); Pareek, Priyasha³ (AUTHOR)

• Source: Journal of the International AIDS Society. Nov2024, Vol. 27 Issue 11, p1-11. 11p.

Record details

Breaking Barriers to an HIV-1 Cure: Innovations in Gene Editing, Immune Modulation, and Reservoir Eradication.

• Authors : Borrajo, Ana¹ (AUTHOR)

• Source: Life (2075-1729). Feb2025, Vol. 15 Issue 2, p276. 25p.

Record details

Long-Acting Injectable Antiretroviral Agents for HIV Treatment and Prevention.

• Authors : Yeon-Sook Kim¹

• Source: Infection & Chemotherapy. Dec2021, Vol. 53 Issue 4, p686-695. 10p.

Record details

Overview of Forced Degradation Analysis for FDA Approved Antiretroviral agents: A Review.

• Authors : Lamichhane, Suman¹; Das, Bhaswati²; Adhikari, Rudra Prasad¹

• Source: Journal of Young Pharmacists. Jul-Sep2022, Vol. 14 Issue 3, p273-282. 10p.

Record details

The antiretroviral agents azidothymidine, stavudine, and didanosine have the identical mutational fingerprint in the rpoB region of Escherichia coli.

• Authors : Yaramada, Lekha¹ (AUTHOR); Singh, Sunjum¹ (AUTHOR); Ge, Zoe¹ (AUTHOR)

Subjects: *AZIDOTHYMIDINE; *REVERSE transcriptase inhibitors; *ESCHERICHIA coli

• Source: Environmental & Molecular Mutagenesis. Aug2022, Vol. 63 Issue 7, p329-335. 7p.

Record details